HIMSS Europe Signs a Collaboration Contract with AVISA

HIMSS EuropeHIMSS Europe and AVISA (the Valencia Association of Health Informatics) have signed a collaboration agreement with which HIMSS reaffirms its strong commitment to Spain, being the leading country in Europe in terms of its adoption and use of electronic medical records.

The signing of the contract took place last weekend within the framework of the fifth edition of AVISA Technical Day, which is celebrated in Alicante and carries the motto "The time for Health Informatics". Cayetano Hernández Marín, president of AVISA and Manuel Vallina, HIMSS senior advisor in Spain, were present at the signing.

According to Manuel Vallina, "this collaboration reflects HIMSS Europe's intentions of being present in the Spanish market, which is of great importance to the organization. We achieve this through collaborating with benchmark institutions in the sector and the organization of training and outreach events. In this case, we formalized the collaboration with AVISA and strengthened ties with this important association that allows us to reach IT professionals in the healthcare information technologies sector."

AVISA, created in 2004 with more than 180 associates, is a renowned institution both in the public and private sector of the Community of Valencia. Its mission is summarized in three points: to be an opinion channel for the promotion and defense of the use of healthcare information systems and technologies, to encourage cooperative relationships with health informatics and also to organize and promote training, study and cultural activities throughout the health informatics community.

According to its president, Cayetano M. Hernández, who is also an informatics professional at the Hospital Universitari i Politècnic La Fe of Valencia, "nowadays we have agreements signed with different institutions such as the Official College of Informatics Engineers of Valencia, ISACA, PMI and with the National Association of Informatics Appraisers and Judicial Experts (ANTPJI). We are delighted to be able to sign this collaboration agreement with HIMSS Europe as we believe this provides our association with a greater degree of professionalism."

About HIMSS Europe
HIMSS is a cause-based, non-profit organization exclusively focused on providing global leadership for the optimal use of information technology (IT) and management systems for the betterment of healthcare.

Founded 51 years ago, HIMSS and its related organizations are headquartered in Chicago with additional offices in the United States, Europe and Asia.

HIMSS represents more than 50,000 individual members, of which more than two thirds work in healthcare centres and governmental or non-profit organizations. HIMSS also includes over 570 corporate members and more than 225 non-profit organizations that share our mission of transforming healthcare through the effective use of information technology and management systems.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...